Aquestive therapeutics reports second quarter 2021 financial results, provides business update and raises full year revenue guidance

Warren, n.j., aug. 03, 2021 (globe newswire) -- aquestive therapeutics, inc. (nasdaq:aqst), a pharmaceutical company focused on developing and commercializing differentiated products that address patients' unmet needs and solve therapeutic problems, today reported financial results for the second quarter ended june 30, 2021 and provided an update on recent developments in its business.
AQST Ratings Summary
AQST Quant Ranking